Cargando…
Collagen Crosslinking for Keratoconus: Cellular Signaling Mechanisms
Collagen crosslinking (CXL) is a widely used treatment to halt the progression of keratoconus (KC). Unfortunately, a significant number of patients with progressive KC will not qualify for CXL, including those with corneas thinner than 400 µm. The present study aimed to investigate the molecular eff...
Autores principales: | Karamichos, Dimitrios, Nicholas, Sarah E., Khan, Asher, Riaz, Kamran M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135890/ https://www.ncbi.nlm.nih.gov/pubmed/37189443 http://dx.doi.org/10.3390/biom13040696 |
Ejemplares similares
-
Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus
por: McKay, Tina B., et al.
Publicado: (2019) -
Collagen Crosslinking for Keratoconus
por: Tan, Petrina, et al.
Publicado: (2011) -
Prospective Observational Study Evaluating Systemic Hormones and Corneal Crosslinking Effects in Keratoconus
por: Van, Lyly, et al.
Publicado: (2023) -
Collagen cross-linking impact on keratoconus extracellular matrix
por: Sharif, Rabab, et al.
Publicado: (2018) -
Short-term Outcomes of Collagen Crosslinking for Early Keratoconus
por: Derakhshan, Akbar, et al.
Publicado: (2011)